Secondary hyperparathyroidism
MONDO:0006964Overproduction of parathyroid hormone in response to influence external to the parathyroid glands.
Also known as: secondary hyperparathyroidism, secondary hyperparathyroidism (disease), secondary hyperparathyroidism NOS
34 clinical trials for this condition and its sub-types, 19 tagged with Secondary hyperparathyroidism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Secondary hyperparathyroidism
-
Secondary hyperparathyroidism of renal origin 7 trials · 18 incl. sub-types
1 sub-type
- Renal osteodystrophy 12 trials
-
New hope for kids on dialysis: drug targets overactive glands
Disease control Recruiting nowThis phase 3 trial tests the drug etelcalcetide (Parsabiv) in 24 children aged 2 to 17 with secondary hyperparathyroidism due to chronic kidney disease who are on hemodialysis. The goal is to see if the drug can safely lower parathyroid hormone levels and improve mineral balance.…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for kids with kidney disease: experimental vitamin d pill enters trial
Disease control Recruiting nowThis study tests an extended-release vitamin D capsule (CTAP101) in 40 children aged 8 to 17 with stage 3 or 4 chronic kidney disease, secondary hyperparathyroidism, and low vitamin D. Participants take one capsule daily at bedtime for 8 weeks. The goal is to see how the body pro…
Phase 2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for kids on dialysis: drug targets hormone imbalance
Disease control Recruiting nowThis phase 3 trial tests etelcalcetide (Parsabiv) in 56 children aged 28 days to under 18 years who have secondary hyperparathyroidism and chronic kidney disease and are on hemodialysis. The drug aims to lower parathyroid hormone levels and improve mineral balance. Participants r…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Dual-Target drug aims to beat current therapy for kidney Patients' hormone problem
Disease control Recruiting nowThis Phase 3 trial tests a new drug called MT1013 against an existing drug, cinacalcet, in 424 adults on dialysis who have secondary hyperparathyroidism (overactive parathyroid glands). The study aims to see if MT1013 better controls parathyroid hormone levels and improves bone h…
Phase 3 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New blood test could end painful bone biopsies for kidney disease patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks at tiny genetic molecules called microRNAs can accurately detect bone problems in people with chronic kidney disease. Currently, doctors rely on a bone biopsy, which is invasive and not practical for most patients. The researc…
Sponsor: Thomas Nickolas • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New blood test may reveal bone health in kids on dialysis
Knowledge-focused Recruiting nowThis study tests a new, non-invasive method using calcium isotope ratios in blood to see if the drug cinacalcet improves bone calcium balance in children aged 3-17 who are on dialysis and have secondary hyperparathyroidism. Researchers will measure these ratios before and three m…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists probe parathyroid tumors for clues to better surgery
Knowledge-focused Recruiting nowThis phase 2 study is collecting tumor samples from 839 people with hyperparathyroidism who are having parathyroid surgery. Researchers want to see if the genetic makeup of the tumors (whether they are monoclonal or polyclonal) relates to how many glands are affected and how well…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC